BCG orchitis
- PMID: 31198685
- PMCID: PMC6558253
- DOI: 10.1016/j.eucr.2019.100925
BCG orchitis
Abstract
Intravesical immunotherapy with Bacillus Calmette-Guerin has been shown to decrease tumor recurrence and progression in urothelial carcinoma of the bladder. Its ubiquitous use is further substantiated by its low rates of complications. Our patient is a 63 year old male with a circuitous medical course who presents with epididymoorchitis and scrotal abscess after his second three week cycle of maintenance BCG prompting scrotal exploration which revealed a non-viable testicle and large scrotal induration with abscess. Pathological analysis and initial cultures were negative for mycobacterium but acid-fast cultures eventually demonstrated mycobacterium three months later.
Figures
Similar articles
-
[A Case Diagnosed as Iatrogenic Vesical Tuberculosis 4 Years after Intravesical Immunotherapy Using Bacillus Calmette-Guérin (BCG) for the Treatment of Bladder Carcinoma].Kansenshogaku Zasshi. 2016 Nov;90(6):809-13. Kansenshogaku Zasshi. 2016. PMID: 30277373 Japanese.
-
Tuberculous epididymo-orchitis following intravesical BCG for superficial bladder cancer.J Med Liban. 2002 Jan-Apr;50(1-2):67-9. J Med Liban. 2002. PMID: 12841318
-
Tuberculosis Epididymo-Orchitis Mimicking Malignancy Resulting from Intravesical Bacillus Calmette-Guérin Immunotherapy for Bladder Cancer: A Case Report of a Rare Complication.Diagnostics (Basel). 2022 Nov 2;12(11):2663. doi: 10.3390/diagnostics12112663. Diagnostics (Basel). 2022. PMID: 36359505 Free PMC article.
-
Epididymo-orchitis following intravesical bacillus Calmette-Guérin therapy.Ann Pharmacother. 2000 Apr;34(4):479-82. doi: 10.1345/aph.19212. Ann Pharmacother. 2000. PMID: 10772435 Review.
-
Bacillus Calmette-Guérin immunotherapy for genitourinary cancer.BJU Int. 2013 Aug;112(3):288-97. doi: 10.1111/j.1464-410X.2012.11754.x. Epub 2013 Mar 20. BJU Int. 2013. PMID: 23517232 Review.
References
Publication types
LinkOut - more resources
Full Text Sources